Are Effective COVID Medications Like Ivermectin Being Suppressed Because Their Successful Treatments Could Cause Vaccines to Lose Government Funding?

Excerpt:  By Joe Hoft Published August 21, 2021 at 7:45am 1039 Comments Share(1.9k)TweetGab ShareTelegramShare Guest post by Kevin Moncla Are effective COVID medications like Ivermectin being suppressed because they could cause vaccines to lose government funding? Not very long after the pandemic lockdowns began last year, we heard of a potential treatment for COVID-19 involving the ... Read more

ICU NURSE: “You’re being lied to about COVID.”

https://rumble.com/embed/vigosp/?pub=5zpyl

Former Pfizer VP & Chief Scientist Dr. Michael Yeadon Latest Message on COVID Vaccines

Do Masks Work? A Review Of The Evidence

Excerpt:  BY TYLER DURDEN SUNDAY, AUG 15, 2021 - 07:00 AM Authored by Jeffrey Anderson via City-Journal.org, “Seriously people—STOP BUYING MASKS!” So tweeted then–surgeon general Jerome Adams on February 29, 2020, adding, “They are NOT effective in preventing general public from catching #Coronavirus.” Two days later, Adams said, “Folks who don’t know how to wear them properly tend ... Read more

Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial

Excerpt:  Randomized Controlled Trial Am J Infect Control . 2009 Jun;37(5):417-419. doi: 10.1016/j.ajic.2008.11.002. Epub 2009 Feb 12. Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial Joshua L Jacobs 1, Sachiko Ohde 2, Osamu Takahashi 3, Yasuharu Tokuda 3, Fumio Omata 3, Tsuguya Fukui 3 Affiliations expand PMID: 19216002 DOI: 10.1016/j.ajic.2008.11.002 Abstract Background: Health care workers outside surgical ... Read more

The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence

IRV-6-257 Excerpt:  Influenza Other Respir Viruses. 2012 Jul; 6(4): 257–267. Published online 2011 Dec 21. doi: 10.1111/j.1750-2659.2011.00307.x PMCID: PMC5779801 PMID: 22188875 The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence Faisal bin‐Reza, 1 Vicente Lopez Chavarrias, 2 Angus Nicoll, 1 , 2 and Mary E. Chamberland 1 Author information Article notes Copyright and License information Disclaimer This article has been cited by other articles in ... Read more

Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis

567.full Excerpt:  Jeffrey D. Smith, Colin C. MacDougall, Jennie Johnstone, Ray A. Copes, Brian Schwartz and Gary E. Garber CMAJ May 17, 2016 188 (8) 567-574; DOI: https://doi.org/10.1503/cmaj.150835 Article Figures & Tables Related Content Metrics Responses  PDF Abstract Background: Conflicting recommendations exist related to which facial protection should be used by health care workers to prevent transmission of acute respiratory infections, including pandemic influenza. We performed a ... Read more

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel_ A Randomized Clinical Trial _ Infectious Diseases _ JAMA _ JAMA Network Excerpt:  Original Investigation September 3, 2019 N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care PersonnelA Randomized Clinical Trial Lewis J. Radonovich Jr, MD1; Michael S. Simberkoff, MD2,3; Mary T. Bessesen, MD4,5; et alAlexandria C. Brown, PhD6; Derek A. T. Cummings, PhD7,8; Charlotte A. Gaydos, MD9; Jenna G. Los, MLA9; Amanda E. Krosche, BS9,10; Cynthia L. Gibert, MD11,12; Geoffrey ... Read more

Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial

Full Article:  https://www.medrxiv.org/content/10.1101/2021.05.31.21258081v1.full-text PDF:   View ORCID ProfileAsaf Biber, Michal Mandelboim, Geva Harmelin, Dana Lev, Li Ram, Amit Shaham, Ital Nemet, Limor Kliker, Oran Erster, Eli Schwartz doi: https://doi.org/10.1101/2021.05.31.21258081 Abstract Background Ivermectin, an anti-parasitic agent, also has anti-viral properties. Our aim was to assess whether ivermectin can shorten the viral shedding in patients at an early-stage of COVID-19 infection. Methods The double-blinded trial compared patients receiving ivermectin 0·2 mg/kg for 3 days vs. placebo in non-hospitalized COVID-19 patients. … Read more